Ohsu Knight Cancer Institute

🇺🇸United States

Country: 🇺🇸United States

Ownership: Subsidiary

Employees: -

Market Cap: -

Website: http://www.ohsu.edu/knight-cancer-institute

Clinical Trials

Evaluation of the Change in PSMA Expression in Prostate Cancer in Response to Hormonal Therapy

Phase 4

Recruiting

Conditions: Castration Resistant Prostate Cancer
Castration Sensitive Prostate Cancer
Prostate Adenocarcinoma

Interventions: Drug: Piflufolastat
Procedure: PSMA PET/CT Scan
Procedure: PSMA PET/MRI scan
Procedure: Biospecimen Collection
Other: Electronic Health Record Review

First Posted Date: 2023-06-26

Last Posted Date: 2024-11-22

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 80

Registration Number: NCT05919329

Locations: 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States

Oxygen-Enhanced MRI for Generating Hypoxia Maps in Patients With Intracranial Tumors

Not Applicable

Recruiting

Conditions: Intracranial Neoplasm

Interventions: Procedure: Magnetic Resonance Imaging
Procedure: Oxygen Therapy

First Posted Date: 2023-06-15

Last Posted Date: 2024-03-27

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 20

Registration Number: NCT05904704

Locations: 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States

Use of Virtual Reality Goggles During Chemotherapy Infusion to Reduce Anxiety-Related Symptoms

Not Applicable

Completed

Conditions: Malignant Solid Neoplasm
Malignant Breast Neoplasm
Malignant Thoracic Neoplasm
Hematopoietic and Lymphoid System Neoplasm
Malignant Head and Neck Neoplasm

Interventions: Other: Questionnaire Administration
Other: Virtual Technology Intervention
Behavioral: Telephone-Based Intervention

First Posted Date: 2023-03-31

Last Posted Date: 2023-12-19

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 50

Registration Number: NCT05793957

Locations: 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States

Predicting the Impact of Treatment Toxicities on Health During Cancer ( PATTERN )

Active, not recruiting

Conditions: Malignant Solid Neoplasm
Hematopoietic and Lymphoid Cell Neoplasm

Interventions: Procedure: Assessment of Therapy Complications
Other: Electronic Health Record Review
Other: Medical Device Usage and Evaluation
Other: Survey Administration

First Posted Date: 2023-03-30

Last Posted Date: 2024-05-28

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 200

Registration Number: NCT05790538

Locations: 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States

Evaluating Fluciclovine PET in Patients With Biochemical Recurrence of Prostate Cancer and a Negative PSMA PET

Phase 4

Recruiting

Conditions: Prostate Cancer

Interventions: Drug: Fluciclovine PET/CT

First Posted Date: 2023-02-10

Last Posted Date: 2024-07-05

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 50

Registration Number: NCT05722925

Locations: 🇺🇸
Oregon Health & Science University, Portland, Oregon, United States

Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Solid or or Metastatic Esophagogastric, Hepatopancreaticobiliary, or Lung Cancer

Phase 2

Recruiting

Conditions: Advanced Malignant Solid Neoplasm
Advanced Biliary Tract Carcinoma
Advanced Esophageal Carcinoma
Metastatic Esophageal Carcinoma

Interventions: Drug: Olanzapine
Drug: Placebo Administration
Other: Questionnaire Administration

First Posted Date: 2023-01-30

Last Posted Date: 2024-10-02

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 66

Registration Number: NCT05705492

Locations: 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States

Quantitative MRI Assessment of Breast Cancer Therapy Response

Recruiting

Conditions: Breast Cancer

Interventions: Procedure: Diffusion Weighted Imaging
Procedure: Dynamic Contrast-Enhanced Magnetic Resonance Imaging

First Posted Date: 2023-01-30

Last Posted Date: 2024-06-12

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 135

Registration Number: NCT05704062

Locations: 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States
🇺🇸
University of Washington, Seattle, Washington, United States

Enhancing Skin Cancer Early Detection and Treatment in Primary Care

Not Applicable

Completed

Conditions: Cutaneous Melanoma

Interventions: Behavioral: Training and Education

First Posted Date: 2023-01-09

Last Posted Date: 2024-10-24

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 17

Registration Number: NCT05675709

Locations: 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States

Impact of Dietary Fiber Supplementation on Colonic Mucosal Microbiome

Not Applicable

Recruiting

Conditions: Benign Colorectal Neoplasm
Non-Neoplastic Anal Disorder

Interventions: Dietary Supplement: Dietary Fiber
Procedure: Proctoscopy or anoscopy with Biopsy
Procedure: Colonoscopy
Other: Questionnaire Administration

First Posted Date: 2022-12-09

Last Posted Date: 2024-02-20

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 120

Registration Number: NCT05643859

Locations: 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States

Evaluating the Human Papillomavirus Self-Collection Experience in Individuals Who Have Experienced Sexual Trauma

Completed

Conditions: Human Papillomavirus Infection
Cervical Carcinoma

Interventions: Procedure: HPV Self-Collection
Other: Interview
Other: Survey Administration

First Posted Date: 2022-07-14

Last Posted Date: 2023-06-27

Lead Sponsor: OHSU Knight Cancer Institute

Target Recruit Count: 16

Registration Number: NCT05458869

Locations: 🇺🇸
OHSU Knight Cancer Institute, Portland, Oregon, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy